Literature DB >> 7580266

MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy.

C I Utech1, U Khatibnia, P F Winter, K G Wulle.   

Abstract

The results of 39 patients with severe Graves' ophthalmopathy (GO), who were monitored by magnetic resonance imaging (MRI) and tonography before and after combined immunosuppressive treatment with cyclosporine and corticosteroids, are presented. A correlation was found between the decrease in T2 relaxation time of the superior, medial, and inferior rectus muscle (p < 0.01) and the response to the immunosuppressive treatment. Muscle thickness and intraocular pressure showed less improvement (p < 0.05). The infiltrative eye signs improved partially in correlation with the T2 relaxation time. By distinguishing inflammation of the extraorbital muscles from fibrosis, the T2 relaxation time can help to select patients that benefit from immunosuppressive treatment as well as to monitor the therapeutic effect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7580266     DOI: 10.1089/thy.1995.5.185

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  10 in total

1.  Update on advanced imaging options for thyroid-associated orbitopathy.

Authors:  Michael P Rabinowitz; Jacqueline R Carrasco
Journal:  Saudi J Ophthalmol       Date:  2012-10

2.  A new MRI method for the quantitative evaluation of extraocular muscle size in thyroid ophthalmopathy.

Authors:  K Aydin; K Güven; S Sencer; A Cikim; N Gül; O Minareci
Journal:  Neuroradiology       Date:  2003-02-19       Impact factor: 2.804

3.  Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy.

Authors:  Kai Hou; Tao Ai; Wei-Kun Hu; Ban Luo; Yi-Ping Wu; Rong Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

Review 4.  Extraocular muscle enlargement.

Authors:  Khizar Rana; Valerie Juniat; Sandy Patel; Dinesh Selva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-06-17       Impact factor: 3.535

5.  Diagnostic accuracy of short-time inversion recovery sequence in Graves' Ophthalmopathy before and after prednisone treatment.

Authors:  Fabio Tortora; Mariaevelina Prudente; Mario Cirillo; Andrea Elefante; Maria Paola Belfiore; Francesco Romano; Salvatore Cappabianca; Carlo Carella; Sossio Cirillo
Journal:  Neuroradiology       Date:  2014-02-27       Impact factor: 2.804

6.  Disease activity in Graves' ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score.

Authors:  Fabio Tortora; Mario Cirillo; Marco Ferrara; Maria Paola Belfiore; Carlo Carella; Ferdinando Caranci; Sossio Cirillo
Journal:  Neuroradiol J       Date:  2013-11-07

Review 7.  Recent developments in Graves' ophthalmopathy imaging.

Authors:  G J Kahaly
Journal:  J Endocrinol Invest       Date:  2004-03       Impact factor: 4.256

8.  Clinical and Radiological Findings in Patients with Newly Diagnosed Graves' Ophthalmopathy.

Authors:  Yakup Cevik; Hande Taylan Sekeroglu; Burce Ozgen; Kadriye Erkan Turan; Ali Sefik Sanac
Journal:  Int J Endocrinol       Date:  2021-04-30       Impact factor: 3.257

9.  Extra-ocular muscle MRI in genetically-defined mitochondrial disease.

Authors:  Robert D S Pitceathly; Jasper M Morrow; Christopher D J Sinclair; Cathy Woodward; Mary G Sweeney; Shamima Rahman; Gordon T Plant; Nadeem Ali; Fion Bremner; Indran Davagnanam; Tarek A Yousry; Michael G Hanna; John S Thornton
Journal:  Eur Radiol       Date:  2015-05-21       Impact factor: 5.315

10.  Current insights of applying MRI in Graves' ophthalmopathy.

Authors:  Cheng Song; Yaosheng Luo; Genfeng Yu; Haixiong Chen; Jie Shen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-29       Impact factor: 6.055

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.